BENDHEIM JACK (President and CEO) sold 29.6% of their position (13.46K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $540.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/2/2026ACC: 0001104659-26-009210
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-13.46K
Net shares
Net seller
$540.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
13.46K disposed
Non-Derivative Transactions2
Class A Common Stock
Indirect
Shares
−6.77K
Price / share
$40.12
Trade value
$271.69K
% of position
14.9%
1/29/2026
45.45K→38.67K
Class A Common Stock
Indirect
Shares
−6.69K
Price / share
$40.09
Trade value
$268.35K
% of position
17.3%
1/30/2026
38.67K→31.98K
Total
Net shares
−13.46K
Net value
-$540.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 1/29/2026 | S · Sale | −6.77K | $40.12 | $271.69K | 14.9% | 45.45K | 38.67K |
| Class A Common Stock Indirect | 1/30/2026 | S · Sale | −6.69K | $40.09 | $268.35K | 17.3% | 38.67K | 31.98K |
| Total | −13.46K | -$540.04K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported